Summary

The pet DNA testing market was valued at $394.07 million in 2024 and is estimated to reach $960.66 million by 2034, exhibiting a CAGR of 9.3% from 2025 to 2034. Pet DNA testing is a modern genetic tool that allows pet owners, veterinarians, and breeders to gain insights into breed composition, ancestry, health risks, and inherited traits of an animal. Using a simple cheek swab or saliva sample, laboratories analyze the pet's DNA to detect breed markers and screen for genetic mutations linked to various diseases or conditions. This technology is most used for dogs and cats, helping identify breed mix in adopted pets, uncover potential hereditary health concerns, and guide personalized care or nutrition plans.

With growing awareness of animal health and the human-animal bond, pet DNA testing is becoming an increasingly popular and valuable resource in proactive pet care. The pet DNA testing market is experiencing robust growth driven by several key factors. Increasing pet humanization has led owners to seek more advanced and personalized care for their animals, including genetic testing to understand breed composition, inherited traits, and potential health risks. Technological advancements such as next-generation sequencing and AI-based genetic analysis have made DNA testing more accurate, affordable, and accessible, particularly through saliva-based at-home kits. The growing adoption of pet insurance, which often supports preventive genetic screening, further propels market expansion. However, certain restraints hinder widespread adoption. High costs, especially for comprehensive panels, limit usage in price-sensitive regions, while variability in test accuracy and limited regulatory oversight can reduce consumer trust. In addition, lack of awareness in rural and developing regions remains a barrier.

Despite these challenges, numerous opportunities exist. The rise of direct-to-consumer testing, integration of DNA testing into routine veterinary care, and the development of breed-specific health panels present significant growth. Moreover, the demand for personalized nutrition and wellness plans based on genetic insights is rapidly expanding. Emerging markets such as Asia Pacific are witnessing a surge in pet ownership, creating a high growth environment for DNA testing services.
The pet DNA testing market is segmented into animal type, sample type, test type, end user, and region. On the basis of animal type, it is classified into dogs, cats, and others. On the basis of sample type, the market is segregated into manual saliva, blood, and others. market is studied across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report are Zoetis Inc. (Basepaws Inc.), Mars Inc. (Wisdom Panel), Orivet Genetic Pet Care Limited, Embark Veterinary, Inc., Urban Animal, DNA MY DOG, Neogen Corporation, Genetic Technologies (EasyDNA), Prenetics Global Limited, and Macrogen, Inc. The key players operating in the market have adopted product launch, product approval, and partnership as their key strategies to expand their product portfolio.

Key Benefits For Stakeholders
●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pet DNA testing market analysis from 2024 to 2034 to identify the prevailing pet DNA testing market opportunities.
●The market research is offered along with information related to key drivers, restraints, and opportunities.
●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
●In-depth analysis of the pet DNA testing market segmentation assists to determine the prevailing market opportunities.
●Major countries in each region are mapped according to their revenue contribution to the global market.
●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
●The report includes the analysis of the regional as well as global pet DNA testing market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

● Quarterly Update and* (only available with a corporate license, on listed price)
● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
● Free Upcoming Version on the Purchase of Five and Enterprise User License.
● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
● Free data Pack on the Five and Enterprise User License. (Excel version of the report)
● Free Updated report if the report is 6-12 months old or older.
● 24-hour priority response*
● Free industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
● Additional company profiles with specific to client's interest
● Expanded list for Company Profiles
● Historic market data

Key Market Segments
By Sample Type
● Saliva
● Blood
● Others

By Animal Type
● Dogs
●Cats
● Others

By Test Type
● Breed Profiles
● Genetic Diseases
● Others

By End User
● Breeders
●Pet Owners
● Veterinarians

By Region
● North America
○ U.S.
○ Canada
○ Mexico
● Europe
○ Germany
○ France
○ UK
○ Italy
○ Spain
○ Rest of Europe
● Asia-Pacific
○ Japan
○ China
○ India
○ Australia
○ South Korea
○ Rest of Asia-Pacific
● LAMEA
○ Brazil
○ Saudi Arabia
○ South Africa
○ Rest of LAMEA

● Key Market Players
○ Zoetis Inc.
○ Mars Inc.
○ DNA My Dog
○ Embark Veterinary, Inc.
○ Genetic Technologies Ltd.
○ Urban Animal
○ Neogen Corporation
○ Orivet Genetic Pet Care Limited
○ Macrogen, Inc.
○ Prenetics Global Limited

ページTOPに戻る

Table of Contents

CHAPTER 1: INTRODUCTION

1.1. Report description


1.2. Key market segments


1.3. Key benefits to the stakeholders


1.4. Research methodology

1.4.1. Primary research


1.4.2. Secondary research


1.4.3. Analyst tools and models


CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective


CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope


3.2. Key findings

3.2.1. Top impacting factors


3.2.2. Top investment pockets


3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers

3.3.2. Moderate threat of new entrants

3.3.3. High threat of substitutes

3.3.4. High intensity of rivalry

3.3.5. Moderate bargaining power of buyers

3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Surge in ownership of companion animals

3.4.1.2. Rise in animal health expenditure

3.4.1.3. Increasing Adoption of Pet DNA Testing for Breed Authentication and Ethical Breeding Practices

3.4.2. Restraints

3.4.2.1. High Cost and Limited Affordability in Developing Regions

3.4.3. Opportunities

3.4.3.1. Surge in awareness related to animal healthcare

CHAPTER 4: PET DNA TESTING MARKET, BY ANIMAL TYPE
4.1. Overview

4.1.1. Market size and forecast

4.2. Dogs
4.2.1. Key market trends, growth factors and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market share analysis by country

4.3. Cats
4.3.1. Key market trends, growth factors and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market share analysis by country

4.4. Others
4.4.1. Key market trends, growth factors and opportunities

4.4.2. Market size and forecast, by region

4.4.3. Market share analysis by country

CHAPTER 5: PET DNA TESTING MARKET, BY SAMPLE TYPE
5.1. Overview

5.1.1. Market size and forecast

5.2. Saliva
5.2.1. Key market trends, growth factors and opportunities

5.2.2. Market size and forecast, by region

5.2.3. Market share analysis by country

5.3. Blood
5.3.1. Key market trends, growth factors and opportunities

5.3.2. Market size and forecast, by region

5.3.3. Market share analysis by country

5.4. Others
5.4.1. Key market trends, growth factors and opportunities

5.4.2. Market size and forecast, by region

5.4.3. Market share analysis by country

CHAPTER 6: PET DNA TESTING MARKET, BY TEST TYPE
6.1. Overview

6.1.1. Market size and forecast

6.2. Breed Profiles
6.2.1. Key market trends, growth factors and opportunities

6.2.2. Market size and forecast, by region

6.2.3. Market share analysis by country

6.3. Genetic Diseases
6.3.1. Key market trends, growth factors and opportunities

6.3.2. Market size and forecast, by region

6.3.3. Market share analysis by country

6.4. Others
6.4.1. Key market trends, growth factors and opportunities

6.4.2. Market size and forecast, by region

6.4.3. Market share analysis by country

CHAPTER 7: PET DNA TESTING MARKET, BY END USER
7.1. Overview

7.1.1. Market size and forecast

7.2. Breeders
7.2.1. Key market trends, growth factors and opportunities

7.2.2. Market size and forecast, by region

7.2.3. Market share analysis by country

7.3. Pet Owners
7.3.1. Key market trends, growth factors and opportunities

7.3.2. Market size and forecast, by region

7.3.3. Market share analysis by country

7.4. Veterinarians
7.4.1. Key market trends, growth factors and opportunities

7.4.2. Market size and forecast, by region

7.4.3. Market share analysis by country

CHAPTER 8: PET DNA TESTING MARKET, BY REGION
8.1. Overview

8.1.1. Market size and forecast By Region

8.2. North America
8.2.1. Key market trends, growth factors and opportunities

8.2.2. Market size and forecast, by Animal Type

8.2.3. Market size and forecast, by Sample Type

8.2.4. Market size and forecast, by Test Type

8.2.5. Market size and forecast, by End User

8.2.6. Market size and forecast, by country
8.2.6.1. U.S.

8.2.6.1.1. Market size and forecast, by Animal Type
8.2.6.1.2. Market size and forecast, by Sample Type
8.2.6.1.3. Market size and forecast, by Test Type
8.2.6.1.4. Market size and forecast, by End User

8.2.6.2. Canada

8.2.6.2.1. Market size and forecast, by Animal Type
8.2.6.2.2. Market size and forecast, by Sample Type
8.2.6.2.3. Market size and forecast, by Test Type
8.2.6.2.4. Market size and forecast, by End User

8.2.6.3. Mexico

8.2.6.3.1. Market size and forecast, by Animal Type
8.2.6.3.2. Market size and forecast, by Sample Type
8.2.6.3.3. Market size and forecast, by Test Type
8.2.6.3.4. Market size and forecast, by End User

8.3. Europe
8.3.1. Key market trends, growth factors and opportunities

8.3.2. Market size and forecast, by Animal Type

8.3.3. Market size and forecast, by Sample Type

8.3.4. Market size and forecast, by Test Type

8.3.5. Market size and forecast, by End User

8.3.6. Market size and forecast, by country
8.3.6.1. Germany

8.3.6.1.1. Market size and forecast, by Animal Type
8.3.6.1.2. Market size and forecast, by Sample Type
8.3.6.1.3. Market size and forecast, by Test Type
8.3.6.1.4. Market size and forecast, by End User

8.3.6.2. France

8.3.6.2.1. Market size and forecast, by Animal Type
8.3.6.2.2. Market size and forecast, by Sample Type
8.3.6.2.3. Market size and forecast, by Test Type
8.3.6.2.4. Market size and forecast, by End User

8.3.6.3. UK

8.3.6.3.1. Market size and forecast, by Animal Type
8.3.6.3.2. Market size and forecast, by Sample Type
8.3.6.3.3. Market size and forecast, by Test Type
8.3.6.3.4. Market size and forecast, by End User

8.3.6.4. Italy

8.3.6.4.1. Market size and forecast, by Animal Type
8.3.6.4.2. Market size and forecast, by Sample Type
8.3.6.4.3. Market size and forecast, by Test Type
8.3.6.4.4. Market size and forecast, by End User

8.3.6.5. Spain

8.3.6.5.1. Market size and forecast, by Animal Type
8.3.6.5.2. Market size and forecast, by Sample Type
8.3.6.5.3. Market size and forecast, by Test Type
8.3.6.5.4. Market size and forecast, by End User

8.3.6.6. Rest of Europe

8.3.6.6.1. Market size and forecast, by Animal Type
8.3.6.6.2. Market size and forecast, by Sample Type
8.3.6.6.3. Market size and forecast, by Test Type
8.3.6.6.4. Market size and forecast, by End User

8.4. Asia-Pacific
8.4.1. Key market trends, growth factors and opportunities

8.4.2. Market size and forecast, by Animal Type

8.4.3. Market size and forecast, by Sample Type

8.4.4. Market size and forecast, by Test Type

8.4.5. Market size and forecast, by End User

8.4.6. Market size and forecast, by country
8.4.6.1. Japan

8.4.6.1.1. Market size and forecast, by Animal Type
8.4.6.1.2. Market size and forecast, by Sample Type
8.4.6.1.3. Market size and forecast, by Test Type
8.4.6.1.4. Market size and forecast, by End User

8.4.6.2. China

8.4.6.2.1. Market size and forecast, by Animal Type
8.4.6.2.2. Market size and forecast, by Sample Type
8.4.6.2.3. Market size and forecast, by Test Type
8.4.6.2.4. Market size and forecast, by End User

8.4.6.3. India

8.4.6.3.1. Market size and forecast, by Animal Type
8.4.6.3.2. Market size and forecast, by Sample Type
8.4.6.3.3. Market size and forecast, by Test Type
8.4.6.3.4. Market size and forecast, by End User

8.4.6.4. Australia

8.4.6.4.1. Market size and forecast, by Animal Type
8.4.6.4.2. Market size and forecast, by Sample Type
8.4.6.4.3. Market size and forecast, by Test Type
8.4.6.4.4. Market size and forecast, by End User

8.4.6.5. South Korea

8.4.6.5.1. Market size and forecast, by Animal Type
8.4.6.5.2. Market size and forecast, by Sample Type
8.4.6.5.3. Market size and forecast, by Test Type
8.4.6.5.4. Market size and forecast, by End User

8.4.6.6. Rest of Asia-Pacific

8.4.6.6.1. Market size and forecast, by Animal Type
8.4.6.6.2. Market size and forecast, by Sample Type
8.4.6.6.3. Market size and forecast, by Test Type
8.4.6.6.4. Market size and forecast, by End User

8.5. LAMEA
8.5.1. Key market trends, growth factors and opportunities

8.5.2. Market size and forecast, by Animal Type

8.5.3. Market size and forecast, by Sample Type

8.5.4. Market size and forecast, by Test Type

8.5.5. Market size and forecast, by End User

8.5.6. Market size and forecast, by country
8.5.6.1. Brazil

8.5.6.1.1. Market size and forecast, by Animal Type
8.5.6.1.2. Market size and forecast, by Sample Type
8.5.6.1.3. Market size and forecast, by Test Type
8.5.6.1.4. Market size and forecast, by End User

8.5.6.2. Saudi Arabia

8.5.6.2.1. Market size and forecast, by Animal Type
8.5.6.2.2. Market size and forecast, by Sample Type
8.5.6.2.3. Market size and forecast, by Test Type
8.5.6.2.4. Market size and forecast, by End User

8.5.6.3. South Africa

8.5.6.3.1. Market size and forecast, by Animal Type
8.5.6.3.2. Market size and forecast, by Sample Type
8.5.6.3.3. Market size and forecast, by Test Type
8.5.6.3.4. Market size and forecast, by End User

8.5.6.4. Rest of LAMEA

8.5.6.4.1. Market size and forecast, by Animal Type
8.5.6.4.2. Market size and forecast, by Sample Type
8.5.6.4.3. Market size and forecast, by Test Type
8.5.6.4.4. Market size and forecast, by End User

CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction

9.2. Top winning strategies

9.3. Product mapping of top 10 player

9.4. Competitive dashboard

9.5. Competitive heatmap

9.6. Top player positioning, 2024

CHAPTER 10: COMPANY PROFILES
10.1. Zoetis Inc.
10.1.1. Company overview

10.1.2. Key executives

10.1.3. Company snapshot

10.1.4. Operating business segments

10.1.5. Product portfolio

10.1.6. Business performance

10.1.7. Key strategic moves and developments

10.2. Mars Inc.
10.2.1. Company overview

10.2.2. Key executives

10.2.3. Company snapshot

10.2.4. Operating business segments

10.2.5. Product portfolio

10.2.6. Key strategic moves and developments

10.3. Embark Veterinary, Inc.
10.3.1. Company overview

10.3.2. Key executives

10.3.3. Company snapshot

10.3.4. Operating business segments

10.3.5. Product portfolio

10.4. Orivet Genetic Pet Care Limited
10.4.1. Company overview

10.4.2. Key executives

10.4.3. Company snapshot

10.4.4. Operating business segments

10.4.5. Product portfolio

10.4.6. Key strategic moves and developments

10.5. DNA My Dog
10.5.1. Company overview

10.5.2. Key executives

10.5.3. Company snapshot

10.5.4. Operating business segments

10.5.5. Product portfolio

10.6. Neogen Corporation
10.6.1. Company overview

10.6.2. Key executives

10.6.3. Company snapshot

10.6.4. Operating business segments

10.6.5. Product portfolio

10.6.6. Business performance

10.7. Genetic Technologies Ltd.
10.7.1. Company overview

10.7.2. Key executives

10.7.3. Company snapshot

10.7.4. Operating business segments

10.7.5. Product portfolio

10.7.6. Business performance

10.8. Prenetics Global Limited
10.8.1. Company overview

10.8.2. Key executives

10.8.3. Company snapshot

10.8.4. Operating business segments

10.8.5. Product portfolio

10.8.6. Business performance

10.9. Macrogen, Inc.
10.9.1. Company overview

10.9.2. Key executives

10.9.3. Company snapshot

10.9.4. Operating business segments

10.9.5. Product portfolio

10.9.6. Business performance

10.10. Urban Animal
10.10.1. Company overview

10.10.2. Key executives

10.10.3. Company snapshot

10.10.4. Operating business segments

10.10.5. Product portfolio